EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib

M Hochmair; S Holzer; M Filipits; A Mohn Staudner; P Errhalt; Gudrun Absenger; T Bundalo; M Arns; U Setinek; R Mikes; R Kolb; Martin Schumacher; S Zochbauer Muller; K Patocka; F Haslbauer; J Rudzki; O Burghuber

doi:10.1016/j.jtho.2016.11.1769

EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib

M Hochmair
, S Holzer
, M Filipits
, A Mohn Staudner
, P Errhalt
, Gudrun Absenger
, T Bundalo
, M Arns
, U Setinek
, R Mikes
, R Kolb
, Martin Schumacher
, S Zochbauer Muller
, K Patocka
, F Haslbauer
, J Rudzki
, O Burghuber

Research output: Contribution to journal › Conference abstract

2 Citations (Web of Science)

Original language	English
Journal	Journal of Thoracic Oncology
DOIs	https://doi.org/10.1016/j.jtho.2016.11.1769
Publication status	Published - 2017
Event	IASLC 2016 World Conference on Lung Cancer - Vienna, Austria Duration: 4 Dec 2016 → 7 Dec 2016

Branches of science

302 Clinical Medicine

DOI

10.1016/j.jtho.2016.11.1769

Links

Web of Science

EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib
Hochmair, M. (Author), Holzer, S. (Author), Filipits, M. (Author), Mohn Staudner, A. (Author), Errhalt, P. (Author), Absenger, G. (Author), Bundalo, T. (Author), Arns, M. (Author), Setinek, U. (Author), Mikes, R. (Author), Kolb, R. (Author), Schumacher, M. (Author), Zochbauer Muller, S. (Author), Patocka, K. (Author), Haslbauer, F. (Author), Rudzki, J. (Author) & Burghuber, O. (Author)
2017
Activity: Talk, presentation or poster › Poster

Cite this

Hochmair, M., Holzer, S., Filipits, M., Mohn Staudner, A., Errhalt, P., Absenger, G., Bundalo, T., Arns, M., Setinek, U., Mikes, R., Kolb, R., Schumacher, M., Zochbauer Muller, S., Patocka, K., Haslbauer, F., Rudzki, J., & Burghuber, O. (2017). EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2016.11.1769

@article{1cd1a05eb19043d4a10912041ba0bff3,

title = "EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib",

author = "M Hochmair and S Holzer and M Filipits and \{Mohn Staudner\}, A and P Errhalt and Gudrun Absenger and T Bundalo and M Arns and U Setinek and R Mikes and R Kolb and Martin Schumacher and \{Zochbauer Muller\}, S and K Patocka and F Haslbauer and J Rudzki and O Burghuber",

year = "2017",

doi = "10.1016/j.jtho.2016.11.1769",

language = "English",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

note = "IASLC 2016 World Conference on Lung Cancer ; Conference date: 04-12-2016 Through 07-12-2016",

}

Hochmair, M, Holzer, S, Filipits, M, Mohn Staudner, A, Errhalt, P, Absenger, G, Bundalo, T, Arns, M, Setinek, U, Mikes, R, Kolb, R, Schumacher, M, Zochbauer Muller, S, Patocka, K, Haslbauer, F, Rudzki, J & Burghuber, O 2017, 'EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib', Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2016.11.1769

TY - JOUR

T1 - EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib

AU - Hochmair, M

AU - Holzer, S

AU - Filipits, M

AU - Mohn Staudner, A

AU - Errhalt, P

AU - Absenger, Gudrun

AU - Bundalo, T

AU - Arns, M

AU - Setinek, U

AU - Mikes, R

AU - Kolb, R

AU - Schumacher, Martin

AU - Zochbauer Muller, S

AU - Patocka, K

AU - Haslbauer, F

AU - Rudzki, J

AU - Burghuber, O

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000413055803018

U2 - 10.1016/j.jtho.2016.11.1769

DO - 10.1016/j.jtho.2016.11.1769

M3 - Conference abstract

SN - 1556-0864

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

T2 - IASLC 2016 World Conference on Lung Cancer

Y2 - 4 December 2016 through 7 December 2016

ER -

EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib

Branches of science

DOI

Links

Activities

EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib

Cite this